Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1–42) compared to Aβ(1–40)

Cell surface proteoglycan-mediated uptake and accumulation of the Alzheimer's disease peptide Aβ(1–42) - ScienceDirect

Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling

Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease, BMC Neuroscience

Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics

Designed Cell-Penetrating Peptide Inhibitors of Amyloid-beta Aggregation and Cytotoxicity - ScienceDirect

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease, BMC Neuroscience

In vivo synaptic activity-independent co-uptakes of amyloid β1–42 and Zn2+ into dentate granule cells in the normal brain

The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy